Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a

Irène R. Chassagnon, Claudia A. McCarthy, Yanni K.Y. Chin, Sandy S Pineda, Angelo Keramidas, Mehdi Mobli, Vi Pham, T. Michael De Silva, Joseph W. Lynch, Robert E. Widdop, Lachlan D. Rash, Glenn Frederick King

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Stroke is the second-leading cause of death worldwide, yet there are no drugs available to protect the brain from stroke-induced neuronal injury. Acid-sensing ion channel 1a (ASIC1a) is the primary acid sensor in mammalian brain and a key mediator of acidosis-induced neuronal damage following cerebral ischemia. Genetic ablation and selective pharmacologic inhibition of ASIC1a reduces neuronal death following ischemic stroke in rodents. Here, we demonstrate that Hi1a, a disulfide-rich spider venom peptide, is highly neuroprotective in a focal model of ischemic stroke. Nuclear magnetic resonance structural studies reveal that Hi1a comprises two homologous inhibitor cystine knot domains separated by a short, structurally well-defined linker. In contrast with known ASIC1a inhibitors, Hi1a incompletely inhibits ASIC1a activation in a pH-independent and slowly reversible manner. Whole-cell, macropatch, and single-channel electrophysiological recordings indicate that Hi1a binds to and stabilizes the closed state of the channel, thereby impeding the transition into a conducting state. Intracerebroventricular administration to rats of a single small dose of Hi1a (2 ng/kg) up to 8 h after stroke induction by occlusion of the middle cerebral artery markedly reduced infarct size, and this correlated with improved neurological and motor function, as well as with preservation of neuronal architecture. Thus, Hi1a is a powerful pharmacological tool for probing the role of ASIC1a in acidmediated neuronal injury and various neurological disorders, and a promising lead for the development of therapeutics to protect the brain from ischemic injury.

Original languageEnglish
Pages (from-to)3750-3755
Number of pages6
JournalProceedings of the National Academy of Sciences
Volume114
Issue number14
DOIs
Publication statusPublished - 4 Apr 2017

Keywords

  • Acid-sensing ion channel 1a
  • Ischemia
  • Neuroprotection
  • Stroke
  • Venom peptide

Cite this

Chassagnon, Irène R. ; McCarthy, Claudia A. ; Chin, Yanni K.Y. ; Pineda, Sandy S ; Keramidas, Angelo ; Mobli, Mehdi ; Pham, Vi ; De Silva, T. Michael ; Lynch, Joseph W. ; Widdop, Robert E. ; Rash, Lachlan D. ; King, Glenn Frederick. / Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. In: Proceedings of the National Academy of Sciences. 2017 ; Vol. 114, No. 14. pp. 3750-3755.
@article{ac6904d60e2d4ce79c5faaf2164aa043,
title = "Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a",
abstract = "Stroke is the second-leading cause of death worldwide, yet there are no drugs available to protect the brain from stroke-induced neuronal injury. Acid-sensing ion channel 1a (ASIC1a) is the primary acid sensor in mammalian brain and a key mediator of acidosis-induced neuronal damage following cerebral ischemia. Genetic ablation and selective pharmacologic inhibition of ASIC1a reduces neuronal death following ischemic stroke in rodents. Here, we demonstrate that Hi1a, a disulfide-rich spider venom peptide, is highly neuroprotective in a focal model of ischemic stroke. Nuclear magnetic resonance structural studies reveal that Hi1a comprises two homologous inhibitor cystine knot domains separated by a short, structurally well-defined linker. In contrast with known ASIC1a inhibitors, Hi1a incompletely inhibits ASIC1a activation in a pH-independent and slowly reversible manner. Whole-cell, macropatch, and single-channel electrophysiological recordings indicate that Hi1a binds to and stabilizes the closed state of the channel, thereby impeding the transition into a conducting state. Intracerebroventricular administration to rats of a single small dose of Hi1a (2 ng/kg) up to 8 h after stroke induction by occlusion of the middle cerebral artery markedly reduced infarct size, and this correlated with improved neurological and motor function, as well as with preservation of neuronal architecture. Thus, Hi1a is a powerful pharmacological tool for probing the role of ASIC1a in acidmediated neuronal injury and various neurological disorders, and a promising lead for the development of therapeutics to protect the brain from ischemic injury.",
keywords = "Acid-sensing ion channel 1a, Ischemia, Neuroprotection, Stroke, Venom peptide",
author = "Chassagnon, {Ir{\`e}ne R.} and McCarthy, {Claudia A.} and Chin, {Yanni K.Y.} and Pineda, {Sandy S} and Angelo Keramidas and Mehdi Mobli and Vi Pham and {De Silva}, {T. Michael} and Lynch, {Joseph W.} and Widdop, {Robert E.} and Rash, {Lachlan D.} and King, {Glenn Frederick}",
year = "2017",
month = "4",
day = "4",
doi = "10.1073/pnas.1614728114",
language = "English",
volume = "114",
pages = "3750--3755",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "14",

}

Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. / Chassagnon, Irène R.; McCarthy, Claudia A.; Chin, Yanni K.Y.; Pineda, Sandy S; Keramidas, Angelo; Mobli, Mehdi; Pham, Vi; De Silva, T. Michael; Lynch, Joseph W.; Widdop, Robert E.; Rash, Lachlan D.; King, Glenn Frederick.

In: Proceedings of the National Academy of Sciences, Vol. 114, No. 14, 04.04.2017, p. 3750-3755.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a

AU - Chassagnon, Irène R.

AU - McCarthy, Claudia A.

AU - Chin, Yanni K.Y.

AU - Pineda, Sandy S

AU - Keramidas, Angelo

AU - Mobli, Mehdi

AU - Pham, Vi

AU - De Silva, T. Michael

AU - Lynch, Joseph W.

AU - Widdop, Robert E.

AU - Rash, Lachlan D.

AU - King, Glenn Frederick

PY - 2017/4/4

Y1 - 2017/4/4

N2 - Stroke is the second-leading cause of death worldwide, yet there are no drugs available to protect the brain from stroke-induced neuronal injury. Acid-sensing ion channel 1a (ASIC1a) is the primary acid sensor in mammalian brain and a key mediator of acidosis-induced neuronal damage following cerebral ischemia. Genetic ablation and selective pharmacologic inhibition of ASIC1a reduces neuronal death following ischemic stroke in rodents. Here, we demonstrate that Hi1a, a disulfide-rich spider venom peptide, is highly neuroprotective in a focal model of ischemic stroke. Nuclear magnetic resonance structural studies reveal that Hi1a comprises two homologous inhibitor cystine knot domains separated by a short, structurally well-defined linker. In contrast with known ASIC1a inhibitors, Hi1a incompletely inhibits ASIC1a activation in a pH-independent and slowly reversible manner. Whole-cell, macropatch, and single-channel electrophysiological recordings indicate that Hi1a binds to and stabilizes the closed state of the channel, thereby impeding the transition into a conducting state. Intracerebroventricular administration to rats of a single small dose of Hi1a (2 ng/kg) up to 8 h after stroke induction by occlusion of the middle cerebral artery markedly reduced infarct size, and this correlated with improved neurological and motor function, as well as with preservation of neuronal architecture. Thus, Hi1a is a powerful pharmacological tool for probing the role of ASIC1a in acidmediated neuronal injury and various neurological disorders, and a promising lead for the development of therapeutics to protect the brain from ischemic injury.

AB - Stroke is the second-leading cause of death worldwide, yet there are no drugs available to protect the brain from stroke-induced neuronal injury. Acid-sensing ion channel 1a (ASIC1a) is the primary acid sensor in mammalian brain and a key mediator of acidosis-induced neuronal damage following cerebral ischemia. Genetic ablation and selective pharmacologic inhibition of ASIC1a reduces neuronal death following ischemic stroke in rodents. Here, we demonstrate that Hi1a, a disulfide-rich spider venom peptide, is highly neuroprotective in a focal model of ischemic stroke. Nuclear magnetic resonance structural studies reveal that Hi1a comprises two homologous inhibitor cystine knot domains separated by a short, structurally well-defined linker. In contrast with known ASIC1a inhibitors, Hi1a incompletely inhibits ASIC1a activation in a pH-independent and slowly reversible manner. Whole-cell, macropatch, and single-channel electrophysiological recordings indicate that Hi1a binds to and stabilizes the closed state of the channel, thereby impeding the transition into a conducting state. Intracerebroventricular administration to rats of a single small dose of Hi1a (2 ng/kg) up to 8 h after stroke induction by occlusion of the middle cerebral artery markedly reduced infarct size, and this correlated with improved neurological and motor function, as well as with preservation of neuronal architecture. Thus, Hi1a is a powerful pharmacological tool for probing the role of ASIC1a in acidmediated neuronal injury and various neurological disorders, and a promising lead for the development of therapeutics to protect the brain from ischemic injury.

KW - Acid-sensing ion channel 1a

KW - Ischemia

KW - Neuroprotection

KW - Stroke

KW - Venom peptide

UR - http://www.scopus.com/inward/record.url?scp=85016982389&partnerID=8YFLogxK

U2 - 10.1073/pnas.1614728114

DO - 10.1073/pnas.1614728114

M3 - Article

VL - 114

SP - 3750

EP - 3755

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 14

ER -